Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Joseph Charles Sedlak"'
Autor:
Laura T. Bortolin, Daniel P. Salem, Sanchari Banerjee, Kelly M. Biette, Delaney M. Byrne, Anthony D. Couvillon, Peter A. Duff, Jonian Grosha, MacKenzie Sadie King, Christopher R. Sedlak, Ibukunoluwapo O. Zabroski, Claire Alexander, Karen Copeland, Daniel Gusenleitner, Emily S. Winn-Deen, Eric K. Huang, Bo R. Rueda, Joseph Charles Sedlak
Publikováno v:
Cancer Research. 82:3390-3390
Introduction: Ovarian cancer (OC) is one of the deadliest cancers, with 314,000 new cases and 207,000 deaths globally in 2020. Serum CA125 has been explored as an OC biomarker for the past 40 years, but lacks sensitivity for early stage OC and is not
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5f798c1b46b17931b998c0376ae6f3b4
https://doi.org/10.1158/1538-7445.am2022-3390
https://doi.org/10.1158/1538-7445.am2022-3390
Autor:
Laura Bortolin, Daniel P. Salem, Jonian Grosha, Ibukunoluwapo O. Zabroski, Sanchari Banerjee, Daniel Gusenleitner, Kelly M. Biette, Christopher R. Sedlak, Anthony D. Couvillon, Peter A. Duff, Delaney M. Byrne, MacKenzie Sadie King, Amy Jamieson, Emily S. Winn-Deen, Jessica N. McAlpine, David Huntsman, Steven Skates, Eric K. Huang, Joseph Charles Sedlak
Publikováno v:
Journal of Clinical Oncology. 40:5542-5542
5542 Background: Detection of cancer with improved discrimination compared to current blood tests could be achieved using an approach that assesses extracellular vesicles (EVs). This approach should have high sensitivity (se) because of EVs abundance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6150979f0e6561efd01fdfee45ceb545
https://doi.org/10.1200/jco.2022.40.16_suppl.5542
https://doi.org/10.1200/jco.2022.40.16_suppl.5542